Public-Health Headline: HPV Vaccination and Cancer Prevention

Three claims hiding in one headline

An HPV vaccination headline nearly always bundles three separate claims together, and they need different evidence.

The first is about the virus: HPV causes certain cancers. The second is about the vaccine: it prevents infection with the types that cause most of them. The third is about you or your child: whether vaccination is recommended, and what it changes about screening.

A headline that is accurate on the first two can still leave a reader with the wrong answer to the third. Pulling them apart is the whole job of this page.

What HPV actually is

NCI describes HPV as a group of more than 200 related viruses. More than 40 spread through direct sexual contact. Among those, two types cause most genital warts, and about a dozen can cause cancer.

The cancers NCI names are cervical, anal, oropharyngeal — the back of the throat, including the base of the tongue and tonsils — penile, vulvar, and vaginal.

Two of those matter for how prevention works. Cervical cancer has a screening program, so precancerous changes can be found and removed before cancer develops. The others do not. NCI makes the consequence explicit: there are no formal population screening programs for the non-cervical HPV cancers, so universal vaccination could have a large public health impact there.

What the vaccine covers

The vaccine used in the United States is Gardasil 9. NCI lists the nine types it prevents.

Types 6 and 11 cause about 90% of genital warts. Types 16 and 18 are high-risk types that cause about 70% of cervical cancers, and an even higher share of some other HPV-caused cancers. Types 31, 33, 45, 52 and 58 are five further high-risk types, which NCI says account for an additional 10% to 20% of cervical cancers.

Note what that still leaves out. Some cervical cancers are caused by high-risk types the vaccine does not cover, and NCI is explicit that it does not protect against all of them. That gap is the reason for everything in the screening section below.

A source table

Source	What it can tell you	What it cannot decide for you
NCI HPV vaccine fact sheet	Which HPV types the vaccine covers, who it is recommended for, and how long protection has been observed to last	Whether vaccination is right for one adult over 26
NCI cervical cancer screening	Which screening tests exist and how they are used	What your particular abnormal result means
SEER Cancer Stat Facts	How common cervical cancer is and how outcomes vary by stage across the country	Any individual's outlook

Who it is recommended for

NCI relays the CDC's recommendations, and the age bands are worth reading carefully because they are often reported loosely.

Routine vaccination is recommended at age 11 or 12, and can begin at 9. It is recommended for everyone through age 26 who was not adequately vaccinated earlier.

For adults aged 27 through 45, the picture is different. The vaccine is FDA-approved to that age, but it is not routinely recommended, because more people in that range have already been exposed and so gain less. NCI's guidance is that clinicians can discuss with individual patients in that band whether it makes sense for them.

NCI also notes that vaccination should be delayed until after pregnancy, though pregnancy testing is not required beforehand, and that there is no evidence it affects a pregnancy or harms a fetus.

On doses: the vaccine was licensed for two doses in younger recipients and three in older ones, and NCI reports evidence that one dose gives protection against vaccine-type infection that is not inferior to two.

The question parents actually ask

"Does this mean my daughter can skip screening later?"

No, and NCI answers it directly: because the vaccine does not protect against all cancer-causing HPV types, people who have been vaccinated should follow the same cervical screening recommendations as people who have not.

The greatest protection, in NCI's framing, comes from the combination of vaccination and screening. They catch different things. Vaccination prevents infection with the types it covers. Screening finds cell changes caused by any type, including the ones the vaccine misses.

Our pages on the HPV vaccine and cervical cancer screening cover each in detail.

When to get checked

Screening is for people without symptoms. Any of these needs an appointment regardless of when your last test was:

• Bleeding between periods, after sex, or at any point after menopause.
• Vaginal discharge that is new and persistent, watery, or blood-stained.
• Pelvic pain or pain during sex that keeps returning.
• An abnormal screening result you have not had followed up.

Bleeding after menopause should be assessed promptly. Most causes are not cancer, and identifying which one is a short piece of medicine.

For scale: the American Cancer Society projects about 13,490 new cervical cancers in the United States in 2026 and about 4,200 deaths, a forecast SEER carries on its cervix page. About 41% are found while still confined to the cervix, where five-year relative survival is 91.8%; it is 64.0% with spread to nearby nodes and 20.5% with distant spread. Those are averages across a large group diagnosed years ago and describe a population, not a person.

What this does not mean

• Vaccination is prevention, not treatment. NCI states plainly that the vaccine does not treat existing HPV infection or HPV-caused disease.
• HPV vaccination does not protect against other sexually transmitted infections.
• A high-level statistic about population impact says nothing about any individual's risk, and cannot be read backward to explain one person's diagnosis.
• A headline about cancer rates in one country, one age group, or one time period is not a general statement about the vaccine's effect everywhere.

Questions patients and parents can ask

• Given my age, or my child's, is HPV vaccination recommended or worth discussing?
• How many doses apply in our case?
• I was vaccinated — which cervical screening schedule should I be on?
• What follow-up is needed after an abnormal HPV or Pap result, and by when? Our page on what to ask after an abnormal HPV test sets out the sequence.

Sources

• NCI: Human Papillomavirus (HPV) Vaccine Fact Sheet
• NCI: Cervical Cancer Screening
• NCI SEER Cancer Stat Facts: Cervical Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.